The aim of this study was to evaluate the analgesic efficacy of sphenopalatine ganglion block performed under general anesthesia in patients undergoing functional endoscopic sinus surgery (FESS) with operative blood loss and postoperative complications (headache, visual disturbances, nausea, vomiting, sore throat, swallow difficulty). Forty-five consenting patients were randomized to receive bilateral sphenopalatine ganglion block with saline (Group S, n = 15), bupivacaine 0.5% (Group B, n = 15), or levobupivacaine 0.5% (Group L, n = 15) immediately following induction of general anesthesia. Esmolol was given during the intraoperative period for a 20% increase in arterial mean pressure or heart rate. Postoperative pain scores were checked on arrival at the postanesthesia care unit, 2, 6, and 24 h after surgery and diclofenac was administered intramuscularly for pain score ≥ 4. A statistically significant reduction was present in postoperative Visual Analog Scale scores between Group S and the block Groups B and L (p < 0.05). In Group L and B, fewer patients required additional analgesics in the postoperative 24 h (p < 0.0001). The comparison of postoperative complications was not statistically significant among the groups (p > 0.05). Sphenopalatine ganglion block with bupivacaine or levobupivacaine improved postoperative analgesia associated with better surgeon and patient satisfaction after FESS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-011-1702-zDOI Listing

Publication Analysis

Top Keywords

sphenopalatine ganglion
16
ganglion block
16
postoperative analgesia
8
functional endoscopic
8
endoscopic sinus
8
sinus surgery
8
general anesthesia
8
postoperative complications
8
05% group
8
groups 005
8

Similar Publications

Sphenopalatine ganglion block for postoperative analgesia after transsphenoidal hypophysectomy: A pilot study.

Eur J Anaesthesiol

January 2025

From the Department of General and Specialised Surgery, Anaesthesiology (ARA, ILC), Postgraduate Program in Medical Sciences (BMB), Fluminense Federal University, Niterói, Brazil and Department of Surgery, Anaesthesiology, Postgraduate Program in Surgical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (NV).

View Article and Find Full Text PDF

Postdural puncture headache: Beyond the evidence.

Best Pract Res Clin Anaesthesiol

September 2024

Yale Medicine/Yale New Haven Health System, USA. Electronic address:

Despite advances in procedural techniques and equipment, postdural puncture headache (PDPH) remains a serious complication of labour epidural analgesia after accidental dural puncture (ADP). Often considered a temporary inconvenience, PDPH can be debilitating in the short term. It can also be associated with chronic manifestations and serious complications.

View Article and Find Full Text PDF

Sphenopalatine ganglion stimulation for the treatment of cerebrovascular ischemia.

Clin Auton Res

December 2024

Facultad de Medicina, Universidad Autónoma de Sinaloa, C. Sauces, s/n, 80019, Culiacán, SIN, Mexico.

Purpose: The parasympathetic effects of the sphenopalatine ganglion (SPG) on the cerebral vasculature provide a compelling rationale for its therapeutic application in cerebrovascular ischemia. In recent years, attempts have been made to stimulate the SPG to achieve beneficial effects on cerebral circulation.

Methods: This review synthesizes the available publications on SPG stimulation.

View Article and Find Full Text PDF

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours that originate from chromaffin cells and occur in the adrenal medulla and in the sympathetic or parasympathetic ganglia. Nearly 70% of PPGLs result from germline or somatic mutations in a single driver gene. The aim of this study was to characterize the genetic background and clinical characteristics related to genetic profile of patients with PPGLs from Romania.

View Article and Find Full Text PDF
Article Synopsis
  • * Fourteen patients who struggled with traditional oral medications received fluoroscopy-guided injections, resulting in significant reductions in both pain scores and frequency of pain attacks after 60 days.
  • * Complications included temporary side effects like hemifacial palsy and diplopia, which resolved within three months, suggesting the treatment is relatively safe.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!